RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Showing results 1 to 20 of 42.

Impact

Mapping the Kappa Opioid Receptor Using RTI's JDTic Compound

April 04, 2016
Expert

Yanan Zhang

News Release

FDA Approves Breakthrough Drug to Treat Extensively Drug-Resistant Tuberculosis

August 14, 2019
Event

Southeast Regional Meeting of the American Chemical Society 2023 Annual Meeting

October 25, 2023
Impact

Ulipristal Acetate

April 11, 2016
Expert

Gabriel A. Knudsen

RTI In The Media

Doris Rouse's Lifelong Journey to Save Those Suffering from Tuberculosis

November 08, 2019 - Triangle Business Journal
Focus Area

Preventing Substance Use

RTI In The Media

FDA OKs 'Game Changer' Pretomanid for Highly Resistant TB

August 15, 2019 - Medscape
Expert

Mark Levi

RTI In The Media

RTP-Based APIE Therapeutics, RTI Team Up to Develop Drug for Rare Lung Disease

August 26, 2020 - WRAL TechWire
News Release

RTI International Licenses Portfolio of Compounds to APIE Therapeutics

August 25, 2020
Impact

Novel Solutions: The Chemistry Center for Combating Antibiotic Resistant Bacteria (CC4CARB)

September 26, 2022
RTI In The Media

Drug Resistant TB: ‘Groundbreaking’ Drug Approved by U.S. Regulators

August 14, 2019 - The Telegraph
Expert

Kenneth Rehder

RTI In The Media

Triangle biotech startup aims to slow disease progression with RTI compounds

March 23, 2023 - WRAL TechWire
RTI In The Media

Breakthrough in Fight Against Multi-Resistant Tuberculosis

September 02, 2019 - Forbes
RTI In The Media

Drug Resistant TB: ‘Groundbreaking’ Drug Approved by U.S. Regulators

August 15, 2019 - Yahoo News UK
Expert

Chunyang Jin

Expert

Scott Runyon